Life Science Pharmacy Recalls TRI-EST Gels Due to Penicillin Contamination
Life Science Pharmacy Inc. is recalling TRI-EST Gels because they may be contaminated with penicillin.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a high-risk allergen (penicillin) contamination where injury has not yet been reported, fitting the High severity criteria.
Plain-English summary
Life Science Pharmacy Inc. is recalling TRI-EST Gels, a prescription compounded product, due to potential contamination with penicillin. The recall covers all lots of the product distributed nationwide.
The hazard is the presence of penicillin, which poses a risk to individuals with penicillin allergies. The source text does not specify the number of units affected or report any illnesses or injuries.
Consumers with this product should contact their healthcare provider or pharmacist for instructions on how to proceed.
The recalled product
- Product
- TRI-EST Gels, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY
- Manufacturer
- Life Science Pharmacy Inc
- Category
- Drug — Compounded Prescription
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 23 recalled by Life Science Pharmacy Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Life Science Pharmacy Inc
See all →- HighLife Science Pharmacy Recalls Compounded Estriol Suppositories Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls TRI-EST Lozenges Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls HCG Injections Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- HighLife Science Pharmacy Recalls Compounded Estriol Vaginal Creams
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls Compounded Estriol Creams Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
Same hazard · allergen penicillin
See all →- HighFreedom Pharmaceuticals Recalls Domperidone API Due to Penicillin Cross-Contamination
FDA (Drugs) · 2016-01-20
- HighLife Science Pharmacy Recalls Compounded Estriol Gels Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- HighBi-Est Testosterone Cream Recalled for Penicillin Cross Contamination
FDA (Drugs) · 2015-09-09
- HighArtesunate Injection Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-09-09
- HighEstradiol Cream Recalled for Potential Penicillin Cross Contamination
FDA (Drugs) · 2015-09-09
Similar recalls
- SeverePerry Drug Recalls Tri-Mix Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-12-03
- HighAttix Pharmaceuticals Recalls Exemestane API Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- HighTriMix Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-01-18
- SevereAttix Pharmaceuticals Recalls Trichlormethiazide Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Rivaroxaban API Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29
- SevereAttix Pharmaceuticals Recalls Tetracaine HCl Due to Penicillin Cross-Contamination Risk
FDA (Drugs) · 2015-04-29